GlobeNewswire Inc.··NaExicure Partners with Adbiotech to Advance Burixafor in Cancer and Blood Disorders
Exicure partners with Korea's Adbiotech on co-development of Burixafor for sickle cell disease, leukemia, and solid tumors, targeting IND studies and clinical trials.
XCURclinical developmentsickle cell disease